Meningitis Imaging Market Expected to Reach $164.70 thousand by 2030-Allied Market Research

According to a new report published by Allied Market Research, titled, “Meningitis Imaging Market by Product Type, Disease Type, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2030,"the meningitis imaging market was valued at $164.70 thousand in 2020, and is estimated to reach $243.72 thousand by 2030, growing at a CAGR of 4.0% from 2021 to 2030.

Meningitis is an inflammatory disease caused by bacteria. It is a medical condition in which inflammation of the membrane surrounds a person’s brain and spinal cord. Swelling meningitis activates symptoms such as headache, fever, and stiff neck. Meningitis can be caused by various sources comprising ear and sinus infection, skull fracture, or rarely after some surgeries. In addition, bacteria that enter bloodstream and travel to the brain and spinal cord cause acute bacterial meningitis.

CT scans may show infection in other areas that may be associated with meningitis. Computer tomography   scanning is a painless, noninvasive procedure. The time of a CT treatment varies depending on size of the area being scanned and it generally only takes a few minutes to half an hour. CT scan is usually conducted as an outpatient procedure in a hospital or a radiology facility, with no overnight hospital stay. It is utilized to guide procedures such as surgery, biopsy, and radiation therapy.

It is a useful diagnostic tool for detection of various diseases and injuries associated with brain and spinal cord. It enables providers to closely examine, blood vessels and detect any suspicious growth of bacterial infection. Furthermore, growth of the meningitis imaging market is majorly driven by increase in prevalence of geriatric population leading to rise in chronic diseases, which leads to fungal meningitis and rise in cases of infectious diseases has led to surge the usage of imaging systems anticipated to enhance the growth of meningitis imaging market. . Furthermore, rapid technological upgradations that requires less time in diagnosis of meningitis is a major aspect for meningitis diagnosis by utilization of imaging technologies.

Moreover, launch of various products to fulfill the unmet medical demands of imaging systems to detect the infections, monitor the efficacy of treatment, and initiatives taken by governments for early diagnosis and treatment further boost the market growth. For instance, in October 2021, Siemens Healthineers announced the USFDA 510 (k) clearance for the Naeotom Alpha, the world’s first photon-counting computer tomograph. It is designed to transform information from X-ray photons that pass through a patient's body, and are received by a detector, into a detailed 3D image. In addition, in February 2020, HCG launched first digital PET CT scanner in Karnataka, India. It improves accuracy and performance to see a world of precision in PET imaging.

Thus, the aforementioned factors are anticipated to drive growth of the meningitis imaging market. In addition, improvement in development of innovative technologies in the healthcare sector, propels growth of the market.

The meningitis imaging market is segmented on the basis of type, application, end user, and region. On the basis of type, the market is divided into computed tomography, magnetic resonance imaging, and positron emission tomography. The computed tomography segment dominated the market in 2020, and is expected to continue this trend during the forecast period.

By application, the market is fragmented into bacterial meningitis, viral meningitis fungal meningitis, and others. The viral meningitis segment led the market in 2020, and is expected to retain its dominance during the forecast period.

By end user, the market is categorized into hospitals & clinic and diagnostic centers. The hospitals & clinics segment exhibited the highest growth in 2020, and is expected to continue this trend during the forecast period, owing to rise in meningitis diseases.

Key Findings Of The Study

• By type, the computer tomography segment was the highest contributor to the market in 2020.
• On the basis of disease type, the viral meningitis segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
• Depending on end user, the hospitals & clinic segment was the highest contributor to the market in 2020.
• Region wise, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

North America accounted for a majority of the global meningitis imaging market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of chronic diseases, consumer awareness for early diagnosis, presence of key players, increase in healthcare expenditure, advancements in applications, and rise in government initiatives in the region. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in incidences of cancer, escalating demand for healthcare services from an aging population, and increased investments in the healthcare sector in the region